EssilorLuxottica unveils four-year clinical trial results of its Essilor Stellest lens at the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Latest findings released for the first time show sustained myopia control efficacy of the lens in children, saving more than one and a quarter dioptres of myopia over four years

Four-year data follows the recent publication of the three-year clinical trial findings in American Journal of Ophthalmology, which also highlights evidence of continued myopia control efficacy of the lens.